Delivery Order SPE2DB20D2001-SPE2DB22FM66Q
Award Date
7/29/22
Potential Completion Date
8/1/22
Potential Value
$9.2K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $38,549.15, is a Firm Fixed Price Delivery Order for the supply of 4,562,688 units of Ropinirole HCL 1 mg tablets. The ultimate completion date for this order is November 3, 2023. This award is associated with a larger $999,999,999 Indefinite Delivery Contract (IDC) that...
This is a Firm Fixed Price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,023.78, is for the supply of Ropinirole HCL ER 6 mg tablets. The contract has a performance period through March 31, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,593.30, is for the delivery of ropinirole HCL ER 8 mg tablets. This is a firm-fixed-price delivery order contract with a completion date of February 4, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award, valued at $2,406.94, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the delivery of Ropinirole HCL ER 6 mg Tablets in 30-count packages. The contract is a firm fixed-price delivery order with an ultimate completion date of October 10, 2024. AmerisourceBergen, a major pharmaceutical distributor, is supplying these essential medications to support military treatment facilities and other government healthcare programs. The contract...
This federal contract award, valued at $1,199.12, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of 4,567,990,774 tablets of Ropinirole HCL ER 2 mg, a medication used to treat Parkinson's disease. The contract has an ultimate completion date of April 23, 2025 and is a firm fixed-price, non-set-aside contract. Amerisourcebergen Drug Corp holds a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Ropinirole HCl ER 2 mg tablets. The contract has a ceiling value of $1,801.86 and is set to expire on August 5, 2024. This delivery order is likely part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at up to $999,999,999, which enables the government to...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is a Delivery Order issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $1,025.74 Firm Fixed Price contract is for the delivery of 4565441737 - Ropinirole HCL ER 12 mg Tablet 30s. The contract does not have a set-aside designation and is expected to be completed by August 14, 2024. Amerisourcebergen, one of the largest pharmaceutical distributors in the U.S., has been awarded numerous...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of ropinirole hydrochloride extended-release 6 mg tablets. The firm-fixed-price delivery order, valued at $1,260.55, has a period of performance through September 27, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 between AmerisourceBergen and the DLA Troop Support Medical for...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,596.22 firm-fixed-price delivery order is for the supply of ropinirole HCl ER 8 mg tablets, with a performance period through August 2024. No set-aside designation was used for this award. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract award, valued at $2,135.79, is for the delivery of ropinirole HCL ER 6 mg tablets. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical. This IDC serves as a primary vehicle for providing a...